2 most recent filings and news items mentioning AWHL. Updated every 60 seconds.
OfferingJun 9, 2026Neutral
Aspira Women's Health Inc. filed a warrant agreement allowing holders to purchase common stock between June 5, 2026 and June 5, 2029. The warrant issuance is a financing mechanism that provides the company with capital flexibility while offering investors equity upside potential.
View filing at SEC.gov →
OtherMay 26, 2026Positive
Aspira Women's Health Inc. has entered into a Master Collaboration and License Agreement with The Cleveland Clinic Foundation for biomedical research and development projects in women's health diagnostics. The partnership leverages CCF's research capabilities and Aspira's diagnos
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.